Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 6 clinical trials
Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children Known or Suspected to be Caused by Susceptible Gram-positive Organisms Including MRSA

To determine the safety and descriptive efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections in children, aged birth to 17 years (inclusive), known or

drainage
procalcitonin
antibiotics
neutrophils
induration
  • 0 views
  • 24 Jan, 2021
  • 96 locations
Study to Optimize the Use of New Antibiotics

patients who have received either empirical or targeted treatment with ceftaroline, tedizolid, dalbavancin, ceftazidime-avibactam, ceftolozane-tazobactam and isavuconazole from January 2016 to December

antibiotics
vancomycin
antibiotic therapy
ceftazidime-avibactam
antimicrobials
  • 3 views
  • 24 Jan, 2021
  • 20 locations
Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections

Because of its prolonged terminal half-life, dalbavancin is an extremely attractive option in treating Gram-positive infections caused by S. aureus including MRSA, and streptococcal species

antibiotics
MRSA
bacterial infections
prosthetic shoulder
vancomycin
  • 211 views
  • 25 Jan, 2021
  • 1 location
DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia

This is a Phase 2b clinical study, multicenter, randomized, open-label, assessor-blinded, superiority study. The study will compare dalbavancin to standard of care antibiotic therapy for the

  • 0 views
  • 01 Aug, 2021
  • 22 locations
Hospital Avoidance Strategies for ABSSSI

More than 40% of patients presenting with acute bacterial skin and skin structure infection (ABSSSI) to the Barnes-Jewish Hospital (BJH) emergency department (ED) are admitted for intravenous antibiotics. There is growing evidence to suggest that many hospital admissions for uncomplicated ABSSSI due to Gram-positive bacteria could be avoided with an …

cefazolin
antibiotics
vancomycin
induration
erythema
  • 0 views
  • 25 Jan, 2021
Evaluation of Intravenous Dalbavancin for Peritonitis

This study evaluates the use of Dalbavancin 1500 mg IV x 1 dose for treating patients with gram positive peritonitis in patients requiring peritoneal dialysis.

  • 0 views
  • 26 Jan, 2021
  • 1 location